# Bally's Corp: financial statements, quarterly

BALY · NYSE · CIK 1747079 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/baly.md) · [Financials](/companies/baly/financials.md) · [Filings](/companies/baly/filings.md) · [Insiders](/companies/baly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/baly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [599](/filings/0001747079-24-000055.md) | [606](/filings/0001747079-24-000089.md) | [632](/filings/0001747079-24-000098.md) | [612 d](/filings/0001747079-25-000039.md) | [618](/filings/0001747079-25-000088.md) | [622](/filings/0001747079-25-000116.md) | [630](/filings/0001747079-25-000140.md) | [580 d](/filings/0001747079-26-000034.md) | [658](/filings/0001747079-26-000084.md) | [664](/filings/0001747079-25-000140.md) | [756](/filings/0001747079-26-000046.md) | [792](/filings/0001747079-26-000084.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [21.6](/filings/0001747079-26-000084.md) | not reported | not reported | [20.3](/filings/0001747079-26-000084.md) |
| Selling, general and administrative | $m | [252](/filings/0001747079-24-000055.md) | [250](/filings/0001747079-24-000089.md) | [231](/filings/0001747079-24-000098.md) | [382 d](/filings/0001747079-25-000039.md) | [248](/filings/0001747079-25-000088.md) | [252](/filings/0001747079-25-000116.md) | [274](/filings/0001747079-25-000140.md) | [269 d](/filings/0001747079-26-000034.md) | [298](/filings/0001747079-26-000084.md) | [292](/filings/0001747079-25-000140.md) | [316](/filings/0001747079-26-000046.md) | [334](/filings/0001747079-26-000084.md) |
| Operating income | $m | [377](/filings/0001747079-24-000055.md) | [6.0](/filings/0001747079-24-000089.md) | [37.2](/filings/0001747079-24-000098.md) | [(316) d](/filings/0001747079-25-000039.md) | [(74.0)](/filings/0001747079-25-000088.md) | [5.6](/filings/0001747079-25-000116.md) | [(158)](/filings/0001747079-25-000140.md) | [(32.3) d](/filings/0001747079-26-000034.md) | [(2.4)](/filings/0001747079-26-000084.md) | [1.0](/filings/0001747079-25-000140.md) | [91.6](/filings/0001747079-26-000046.md) | [(34.0)](/filings/0001747079-26-000084.md) |
| Interest expense | $m | [63.3](/filings/0001747079-24-000055.md) | [67.1](/filings/0001747079-24-000089.md) | [70.6](/filings/0001747079-23-000089.md) | [76.6 d](/filings/0001747079-24-000020.md) | [73.1](/filings/0001747079-24-000055.md) | [74.2](/filings/0001747079-24-000089.md) | [80.3](/filings/0001747079-25-000140.md) | [71.7 d](/filings/0001747079-26-000034.md) | [101](/filings/0001747079-26-000084.md) | [111](/filings/0001747079-25-000140.md) | [112](/filings/0001747079-26-000046.md) | [121](/filings/0001747079-26-000084.md) |
| Income tax | $m | [138](/filings/0001747079-24-000055.md) | [(28.6)](/filings/0001747079-24-000089.md) | [43.9](/filings/0001747079-24-000098.md) | [(151) d](/filings/0001747079-25-000039.md) | [31.4](/filings/0001747079-25-000088.md) | [(1.5)](/filings/0001747079-25-000116.md) | [(33.6)](/filings/0001747079-25-000140.md) | [19.0 d](/filings/0001747079-26-000034.md) | [185](/filings/0001747079-26-000084.md) | [(41.3)](/filings/0001747079-25-000140.md) | [(3.2)](/filings/0001747079-26-000046.md) | [(13.6)](/filings/0001747079-26-000084.md) |
| Net income | $m | [178](/filings/0001747079-24-000098.md) | [(25.7)](/filings/0001747079-24-000098.md) | [(61.8)](/filings/0001747079-24-000098.md) | [(278) d](/filings/0001747079-25-000039.md) | [(174)](/filings/0001747079-25-000116.md) | [(60.2)](/filings/0001747079-25-000116.md) | [(248)](/filings/0001747079-25-000140.md) | [(85.8) d](/filings/0001747079-26-000034.md) | [(228)](/filings/0001747079-26-000084.md) | [(103)](/filings/0001747079-25-000140.md) | [(162)](/filings/0001747079-26-000046.md) | [(146)](/filings/0001747079-26-000084.md) |
| Diluted EPS | $ per share | [3.24](/filings/0001747079-24-000055.md) | [(0.48)](/filings/0001747079-24-000089.md) | [(1.15)](/filings/0001747079-24-000098.md) | not reported | [(3.61)](/filings/0001747079-25-000088.md) | [(1.24)](/filings/0001747079-25-000116.md) | [(5.10)](/filings/0001747079-25-000140.md) | not reported | [(3.76)](/filings/0001747079-26-000084.md) | [(1.70)](/filings/0001747079-25-000140.md) | [(2.69)](/filings/0001747079-26-000046.md) | [(2.41)](/filings/0001747079-26-000084.md) |
| Basic EPS | $ per share | [3.28](/filings/0001747079-24-000055.md) | [(0.48)](/filings/0001747079-24-000089.md) | [(1.15)](/filings/0001747079-24-000098.md) | not reported | [(3.61)](/filings/0001747079-25-000088.md) | [(1.24)](/filings/0001747079-25-000116.md) | [(5.10)](/filings/0001747079-25-000140.md) | not reported | [(3.76)](/filings/0001747079-26-000084.md) | [(1.70)](/filings/0001747079-25-000140.md) | [(2.69)](/filings/0001747079-26-000046.md) | [(2.41)](/filings/0001747079-26-000084.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-02-07) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001747079-25-000039.md) | [0.2](/filings/0001747079-24-000055.md) | [0.2](/filings/0001747079-24-000089.md) | [0.2](/filings/0001747079-24-000098.md) | [0.2](/filings/0001747079-26-000034.md) | [0.2](/filings/0001747079-26-000084.md) | [0.2](/filings/0001747079-25-000088.md) | [0.2](/filings/0001747079-25-000116.md) | [0.2](/filings/0001747079-25-000140.md) | [0.8](/filings/0001747079-26-000084.md) | [0.6](/filings/0001747079-26-000046.md) | [0.4](/filings/0001747079-26-000084.md) |
| Current assets | $bn | [0.6](/filings/0001747079-25-000039.md) | [0.5](/filings/0001747079-24-000055.md) | [0.6](/filings/0001747079-24-000089.md) | [0.5](/filings/0001747079-24-000098.md) | [0.4](/filings/0001747079-26-000034.md) | not reported | [0.6](/filings/0001747079-25-000088.md) | [0.5](/filings/0001747079-25-000116.md) | [0.6](/filings/0001747079-25-000140.md) | [1.3](/filings/0001747079-26-000084.md) | [1.1](/filings/0001747079-26-000046.md) | [1.0](/filings/0001747079-26-000084.md) |
| Total assets | $bn | [6.9](/filings/0001747079-25-000039.md) | [6.6](/filings/0001747079-24-000055.md) | [6.6](/filings/0001747079-24-000089.md) | [6.4](/filings/0001747079-24-000098.md) | [5.9](/filings/0001747079-26-000034.md) | not reported | [7.5](/filings/0001747079-25-000088.md) | [7.8](/filings/0001747079-25-000116.md) | [7.6](/filings/0001747079-25-000140.md) | [11.2](/filings/0001747079-26-000084.md) | [10.9](/filings/0001747079-26-000046.md) | [10.8](/filings/0001747079-26-000084.md) |
| Current liabilities | $bn | [0.9](/filings/0001747079-25-000039.md) | [0.9](/filings/0001747079-24-000055.md) | [0.9](/filings/0001747079-24-000089.md) | [0.9](/filings/0001747079-24-000098.md) | [0.7](/filings/0001747079-26-000034.md) | not reported | [0.8](/filings/0001747079-25-000088.md) | [1.0](/filings/0001747079-25-000116.md) | [0.9](/filings/0001747079-25-000140.md) | [1.7](/filings/0001747079-26-000084.md) | [1.0](/filings/0001747079-26-000046.md) | [1.1](/filings/0001747079-26-000084.md) |
| Total liabilities | $bn | [6.2](/filings/0001747079-25-000039.md) | [6.2](/filings/0001747079-24-000055.md) | [6.2](/filings/0001747079-24-000089.md) | [6.2](/filings/0001747079-24-000098.md) | [5.8](/filings/0001747079-26-000034.md) | not reported | [6.7](/filings/0001747079-25-000088.md) | [7.2](/filings/0001747079-25-000116.md) | [7.0](/filings/0001747079-25-000140.md) | [8.7](/filings/0001747079-26-000084.md) | [8.6](/filings/0001747079-26-000046.md) | [8.6](/filings/0001747079-26-000084.md) |
| Long-term debt | $bn | [3.6](/filings/0001747079-25-000039.md) | [3.7](/filings/0001747079-24-000055.md) | [3.7](/filings/0001747079-24-000089.md) | [3.7](/filings/0001747079-24-000098.md) | [3.3](/filings/0001747079-26-000034.md) | not reported | [3.4](/filings/0001747079-25-000088.md) | [3.6](/filings/0001747079-25-000116.md) | [3.7](/filings/0001747079-25-000140.md) | [4.5](/filings/0001747079-26-000084.md) | [4.4](/filings/0001747079-26-000046.md) | [4.5](/filings/0001747079-26-000084.md) |
| Current portion of debt | $bn | [0.0](/filings/0001747079-25-000039.md) | [0.0](/filings/0001747079-24-000055.md) | [0.0](/filings/0001747079-24-000089.md) | [0.0](/filings/0001747079-24-000098.md) | [0.0](/filings/0001747079-26-000034.md) | not reported | [0.0](/filings/0001747079-25-000088.md) | [0.0](/filings/0001747079-25-000116.md) | [0.0](/filings/0001747079-25-000140.md) | [0.0](/filings/0001747079-26-000084.md) | [0.0](/filings/0001747079-26-000046.md) | [0.0](/filings/0001747079-26-000084.md) |
| Shareholders' equity | $bn | [0.6](/filings/0001747079-25-000039.md) | [0.4](/filings/0001747079-24-000055.md) | [0.4](/filings/0001747079-24-000089.md) | [0.2](/filings/0001747079-24-000098.md) | [0.0](/filings/0001747079-26-000034.md) | [(0.0)](/filings/0001747079-26-000084.md) | [0.8](/filings/0001747079-25-000088.md) | [0.6](/filings/0001747079-25-000116.md) | [0.5](/filings/0001747079-25-000140.md) | [1.0](/filings/0001747079-26-000084.md) | [0.8](/filings/0001747079-26-000046.md) | [0.6](/filings/0001747079-26-000084.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [45.7 d](/filings/0001747079-25-000039.md) | [(16.1)](/filings/0001747079-24-000055.md) | [80.2 d](/filings/0001747079-24-000089.md) | [54.3 d](/filings/0001747079-24-000098.md) | [70.3 d](/filings/0001747079-25-000039.md) | [(7.9)](/filings/0001747079-25-000088.md) | [47.6 d](/filings/0001747079-25-000116.md) | [36.5 d](/filings/0001747079-25-000140.md) | [37.8 d](/filings/0001747079-26-000034.md) | not reported | [(145)](/filings/0001747079-26-000046.md) | [(121) d](/filings/0001747079-26-000084.md) |
| Capital expenditure | $m | [44.9 d](/filings/0001747079-25-000039.md) | [43.7](/filings/0001747079-24-000055.md) | [75.9](/filings/0001747079-24-000089.md) | [147](/filings/0001747079-24-000098.md) | [45.3 d](/filings/0001747079-25-000039.md) | [28.1](/filings/0001747079-25-000088.md) | [35.7](/filings/0001747079-25-000116.md) | [92.3](/filings/0001747079-24-000098.md) | [44.1 d](/filings/0001747079-26-000034.md) | [49.0](/filings/0001747079-25-000116.md) | [38.9](/filings/0001747079-26-000046.md) | [35.1 d](/filings/0001747079-26-000084.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [20.8 d](/filings/0001747079-25-000039.md) | [19.8](/filings/0001747079-24-000055.md) | [10.7 d](/filings/0001747079-24-000089.md) | [0.0 d](/filings/0001747079-24-000098.md) | [68.6 d](/filings/0001747079-25-000039.md) | [0.0](/filings/0001747079-25-000088.md) | [0.0 d](/filings/0001747079-25-000116.md) | [0.0 d](/filings/0001747079-25-000140.md) | [0.0 d](/filings/0001747079-25-000039.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [60.5](/filings/0001747079-23-000081.md) | [57.1](/filings/0001747079-23-000089.md) | [55.1](/filings/0001747079-24-000055.md) | [53.9](/filings/0001747079-24-000089.md) | [53.6](/filings/0001747079-24-000098.md) | [48.1](/filings/0001747079-25-000088.md) | [48.5](/filings/0001747079-25-000116.md) | [48.6](/filings/0001747079-25-000140.md) | [60.7](/filings/0001747079-26-000084.md) | [60.6](/filings/0001747079-25-000140.md) | [60.2](/filings/0001747079-26-000046.md) | [60.6](/filings/0001747079-26-000084.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,469,522 at 2026-07-31, from the cover of the [10-Q filed 2026-08-14](/filings/0001747079-26-000084.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.